FDC116115: A prospective study of sexual function in sexually active men treated for BPH
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Dutasteride/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 16 Oct 2017 Primary endpoint of total MSHQ scores at month 12 has been met, according to results published in the BJU International.
- 16 Oct 2017 Results published in the BJU International
- 23 Apr 2016 This trial is completed in Germany (end date: 5 Apr 2016), according to European Clinical Trials Database record.